Dr. Ramez Bahu, MD

Dr. Bahu practices at Northshore University Healthsystem Faculty Practice Associates in Bannockburn, Illinois.

Dr. Bahu's NPI, 1245591924, was assigned on May 30, 2012. Dr. Bahu holds Illinois license 036.142989.

Dr. Bahu's primary practice is Northshore University Healthsystem Faculty Practice Associates, at 2151 Waukegan Rd, Bannockburn, IL 60015 in Lake County. The practice phone is (847) 570-5235.

Dr. Bahu's primary practice is Northshore University Healthsystem Faculty Practice Associates in Bannockburn, Illinois. Dr. Bahu is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Bahu to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahu practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Bahu's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Bahu is licensed in Illinois.

CMS data shows 917 Medicare services from Dr. Bahu across 8 procedure codes in 2024, for 416 Medicare patients. Medicare paid $67,462 for them.

CMS counts 416 Medicare patients who saw Dr. Bahu in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bahu's median patient age at 68, with 54% women.

In 2024, Dr. Bahu wrote 3,226 Medicare Part D claims for 454 patients. 36% of them were for generic drugs. CMS names the drug for 3,000 of them, across 48 drugs with 11 or more claims each, at $1,554,347 in total drug cost. In 2023, CMS named 2,780 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Bahu for performance year 2024, reported as part of a group. Dr. Bahu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bahu as offering telehealth.

Dmand AI links 7 papers to Dr. Bahu, published from 2012 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Calcitonin, Calcitonin Gene-Related Peptide and Protein Precursors. Dr. Bahu has published most often in Diagn Microbiol Infect Dis. Dr. Bahu's most frequent co-authors are Alexander Hanania, MD, Joseph Do Jabbour, DO and Iba Al Wohoush, MD.

CMS Open Payments shows 4 general payments to Dr. Bahu from 4 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 90% of the total. Horizon Pharma plc paid the most, $65.